Whether you're comparing brand-name Wegovy, Zepbound, Ozempic, and Mounjaro, or a compounded semaglutide or tirzepatide alternative, RENVA reviews pricing, compounding disclosure, pharmacy transparency, lab and monitoring clarity, supply reliability, provider credentials, and cancellation terms — all from public sources. Affiliate relationships are disclosed and never influence scoring.
Providers our editorial team has highlighted based on strong overall transparency and service quality — not a paid placement.
From $199.95/mo
Affiliate-disclosed
Weight Loss / GLP-1 providers ranked by public score and pricing — not affiliate commissions.
GLP-1 menus mix compounded injectables, oral options, and brand-name pens. A single “starting price” often reflects whichever SKU is cheapest on that menu — not the treatment you actually want. Start with the product category below, then open a provider for the full weight-loss pricing list.
Compounded semaglutide
Compounded injectable semaglutide — compare starting prices for the same product family across providers, not a mixed GLP-1 menu.
Compounded tirzepatide
Compounded injectable tirzepatide (including GIP/GLP-1 listings) — compare starting prices within this dual-agonist family.
Oral compounded GLP-1, Foundayo
Oral compounded semaglutide or tirzepatide (lozenges, drops, sublingual) plus Foundayo (orforglipron) — pills, not weekly pens.
Wegovy, Zepbound, Ozempic, Mounjaro
Wegovy, Zepbound, Ozempic, Mounjaro, and Oral Wegovy — FDA-approved brand-name starting prices, separate from compounded menus.
This table ranks scored providers on overall transparency signals. For apples-to-apples product prices, use Shop by Treatment above — compounded injectables, oral GLP-1s, and brand-name pens are not a single starting price. Affiliate relationships are disclosed and do not affect scoring.
Pricing verified August 2026
| Provider | Score | Starting price | Brand vs. compounded | Insurance | Labs included | Action |
|---|---|---|---|---|---|---|
| From $199.95/mo | compounded | No | — | |||
| $49 consult + from $199/mo subscription | compounded (503A/503B) | No | No | |||
| From $99/mo oral sema | $149/mo injectable | Compounded | — | — | |||
Yucca Health Weight LossLongevity | $146/mo sema | $258/mo tirz (6-mo plans) | not_disclosed | No | No | ||
Trimi Weight Loss | From $99/mo (annual) | $175/mo M2M sema | Compounded | No | No | ||
| From $297/mo | Compounded | — | No |
Browse the provider directory to filter by lowest cost, insurance support, compounded option, and more. See Top Picks for algorithmic categories like Best Overall and Lowest Starting Price. Select up to three providers for a side-by-side compare.
More than 30 telehealth companies now offer GLP-1 weight loss medications, and the differences between them go well beyond price. Two providers advertising the same "starting at" number can end up costing very different amounts once you factor in what's actually included — and some of the details that matter most aren't always obvious from a pricing page alone.
Wegovy, Zepbound, Ozempic, and Mounjaro are FDA-approved brand-name medications, typically priced well above $1,000 a month without insurance. Compounded semaglutide and tirzepatide — prepared by licensed pharmacies using the same active ingredient — usually cost $100–$400 a month, but aren't individually FDA-approved as finished products. Neither option is inherently better; the right choice depends on your insurance coverage and how you weigh cost against FDA-approval status. A transparent provider will state clearly, for every medication they offer, which category it falls into — not just call everything "GLP-1 medication" and leave you to guess.
Oral GLP-1 options are also expanding — including Foundayo (orforglipron), a once-daily pill with no food or water timing rules. See our Foundayo vs. Semaglutide vs. Tirzepatide comparison for how that fits alongside injectable brand-name and compounded products.
The number in a provider's ad is often just the entry-level dose, the first-month promotional rate, or the medication cost alone with a separate membership fee added on top. Before comparing two providers, add up every recurring cost you'd actually pay: membership or program fees, medication at your expected maintenance dose (not just the starting dose), labs if required, and shipping. A provider that looks cheapest at first glance can end up costing more once you're a few months in and your dose has increased.
For apples-to-apples product prices — compounded semaglutide, compounded tirzepatide, oral GLP-1s, and brand-name pens — start with Shop by Treatment on this hub, then use the provider compare table for scores, insurance, labs, and pharmacy signals.
Compounded medications are prepared by specific licensed pharmacies, and not all of them have the same regulatory track record. A provider willing to name their compounding pharmacy — rather than describing it vaguely as "a licensed U.S. pharmacy" — is giving you something you can actually verify independently. If a provider won't say who's preparing your medication, that's worth factoring into your decision.
Some providers let you cancel anytime through an online account. Others require an email or phone call, and a few structure their programs so you can't cancel once a prescription has been issued or a program period has started. This is exactly the kind of detail that's easy to miss until you're trying to stop, so it's worth checking before you sign up, not after.
Use these questions to guide your comparison, not the price alone:
RENVA's provider directory tracks these details for every provider we cover, and the preference quiz can help you narrow the list based on what matters most to you before you compare providers side by side.
Use Shop by Treatment for product-level starting prices, then the directory, quiz, or side-by-side compare for scores, pharmacy type, labs, insurance, cancellation, and refunds.
Compare compounded semaglutide, compounded tirzepatide, oral GLP-1s, and brand-name pens before treating a menu "from" price as one category.
Use the preference-based quiz to compare pricing and pharmacy disclosures before account creation or a call.
RENVA highlights practical questions customers and members can ask when comparing GLP-1 providers.
Browse verified monthly pricing, pharmacy disclosure, insurance support, and lab clarity across all scored GLP-1 providers.
Live pricing comparison — advertised vs. true monthly cost, cancellation index, and price transparency scorecard across all scored providers.
Informational only. RENVA does not provide medical advice or clinical decisions.
RENVA organizes public provider details into a preference-based framework so customers and members can compare cost, pharmacy disclosure, monitoring, and support.
Share stated preferences around budget, brand or compounded disclosure, lab visibility, provider access, and shipping clarity.
RENVA tracks listed pricing, pharmacy transparency, lab and monitoring disclosures, supply notes, and cancellation terms.
Use Shop by Treatment for product-level prices, then browse scored providers, side-by-side compare, or the quiz before signing up.
The quiz is informational and preference-based. You can also browse scored providers in the directory, filter by cost and insurance, or compare up to three providers side-by-side. It does not assess health status, make clinical decisions, or provide medical advice.
Tracks whether compounded versus brand offerings are labeled and FDA status notes are visible.
Surfaces whether a named pharmacy or pharmacy type is disclosed before signup.
Reviews whether labs, follow-up cadence, and check-in model are disclosed publicly.
Affiliate status has zero weight in provider scoring and editorial conclusions.
Budget preferences
Monthly cost, lab fees, shipping, and membership terms
Program preferences
Brand or compounded disclosure, supply notes, and pharmacy visibility
Access preferences
Provider interaction, follow-up cadence, and support model
Policy checks
Cancellation, refunds, privacy, and affiliate disclosure
Comparison output
Providers worth comparing based on stated preferences
GLP-1 medications explained in plain language: what they are, how they work in your gut and brain, which drugs are FDA-approved for weight loss, and what clinical trials found.
A clear look at GLP-1 side effects — from common nausea to rare but serious risks — based on FDA labeling and adverse event data, plus what tends to help.
GLP-1 insurance coverage varies enormously by plan type. Here's what commercial insurance, Medicare, and Medicaid actually cover in 2026, plus options if you're uninsured.
Compounded GLP-1 medications aren't FDA-approved and aren't reviewed for safety or quality before they're sold. Here's what that actually means and why the distinction matters.
GLP-1 medications start affecting appetite within days, but meaningful weight loss builds over months. Here's the actual week-by-week timeline from clinical trial data.
Open Shop by Treatment for compounded semaglutide, compounded tirzepatide, oral GLP-1s, or brand-name pens — then take the quiz or compare scored providers side-by-side before signing up.
Preference-based only. Affiliate relationships are disclosed and do not influence scoring.